Event-Driven Stocks

CANTEL MEDICAL LLC

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

Signs5 good1 warningdetails ↓

Financials

SEC XBRL · annual
 FY20FY19FY18FY17FY16FY15
Revenue$288.5M$224.5M$871.9M$770.2M$158.3M$135.4M
Operating income$48.3M$83.5M$121.7M$110.4M$97.3M$80.8M
Net income−$2.3M$18.8M$91.0M$71.4M$15.4M$11.1M
Total assets$2.07B$1.07B$963.7M$786.4M$694.5M$584.0M
Total liabilities$1.34B$408.8M$354.8M$262.4M$240.2M
Equity$729.6M$661.5M$608.9M$523.9M$454.4M$406.6M
EPS (diluted)$-0.05$0.45$2.18$1.71$0.37$0.27
Shares out.42.2M41.8M41.7M41.7M41.7M41.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2020
Operating margin
16.7%
Net margin
−0.8%
Return on equity
−0.3%
Return on assets
−0.1%
Return on capital (ROCE)
2.6%
Liabilities / assets
64.8%
Debt / equity
1.84×
Book value / share
$17.30
Revenue growth (YoY)
28.5%
Net income growth (YoY)
−112.0%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2020
Altman Z″ (distress)
3.07safe
Accruals / assets
6.7%clean
Beneish M-Score
-2.84normal
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
60
/ 100
Profitability 40Growth 50Catalyst 33Earnings quality 100Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

1 warning5 good
  • Reported a net loss
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Insider transactions

SEC Form 4 · most recent
0 acquisitions3 disposalsnet 66,527.431 shares · last 3
InsiderDateTypeSharesPrice
Yellin Seth MOfficer — Executive Vice PresidentJun 2, 2021D41,622$80.59
Pronovost PeterDirectorJun 2, 2021D22,970.431$80.59
Prange KarenDirectorJun 2, 2021D1,935$80.59

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.